These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8288675)
1. Increase of labeling indices in gastrointestinal mucosae of mice and rats by compounds of the okadaic acid type. Yuasa H; Yoshida K; Iwata H; Nakanishi H; Suganuma M; Tatematsu M J Cancer Res Clin Oncol; 1994; 120(4):208-12. PubMed ID: 8288675 [TBL] [Abstract][Full Text] [Related]
2. Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach. Suganuma M; Okabe S; Sueoka E; Nishiwaki R; Komori A; Uda N; Isono K; Fujiki H J Cancer Res Clin Oncol; 1995; 121(9-10):621-7. PubMed ID: 7559747 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of okadaic acid class tumor promoters on mouse skin. Fujiki H; Suganuma M; Yoshizawa S; Nishiwaki S; Winyar B; Sugimura T Environ Health Perspect; 1991 Jun; 93():211-4. PubMed ID: 1663450 [TBL] [Abstract][Full Text] [Related]
4. Okadaic acid enhances prostaglandin E1-induced alkaline phosphatase activity in osteoblast-like cells: regulation at a point downstream from protein kinase A. Ito Y; Suzuki A; Watanabe-Tomita Y; Oiso Y; Kozawa O Prostaglandins Leukot Essent Fatty Acids; 1996 Nov; 55(5):357-61. PubMed ID: 8981633 [TBL] [Abstract][Full Text] [Related]
5. Phosphatase inhibitors potentiate adrenergic-stimulated cAMP and cGMP production in rat pinealocytes. Ho AK; Chik CL Am J Physiol; 1995 Mar; 268(3 Pt 1):E458-66. PubMed ID: 7534989 [TBL] [Abstract][Full Text] [Related]
6. Okadaic acid and dinophysistoxin-1, non-TPA-type tumor promoters, stimulate prostaglandin E2 production in rat peritoneal macrophages. Ohuchi K; Tamura T; Ohashi M; Watanabe M; Hirasawa N; Tsurufuji S; Fujiki H Biochim Biophys Acta; 1989 Sep; 1013(1):86-91. PubMed ID: 2506933 [TBL] [Abstract][Full Text] [Related]
7. A new pathway of tumor promotion by the okadaic acid class compounds. Fujiki H; Suganuma M; Nishiwaki S; Yoshizawa S; Winyar B; Sugimura T; Schmitz FJ Adv Second Messenger Phosphoprotein Res; 1990; 24():340-4. PubMed ID: 2169814 [No Abstract] [Full Text] [Related]
8. Calyculin A, an inhibitor of protein phosphatases, a potent tumor promoter on CD-1 mouse skin. Suganuma M; Fujiki H; Furuya-Suguri H; Yoshizawa S; Yasumoto S; Kato Y; Fusetani N; Sugimura T Cancer Res; 1990 Jun; 50(12):3521-5. PubMed ID: 2160320 [TBL] [Abstract][Full Text] [Related]
9. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855 [TBL] [Abstract][Full Text] [Related]
10. Promotion of BALB/3T3 cell transformation by the okadaic acid class of tumor promoters, okadaic acid and dinophysistoxin-1. Sakai A; Fujiki H Jpn J Cancer Res; 1991 May; 82(5):518-23. PubMed ID: 1905699 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of calyculin A and okadaic acid on the glucose-induced regulation of glycogen synthase and phosphorylase activities in cultured hepatocytes. Pugazhenthi S; Yu B; Gali RR; Khandelwal RL Biochim Biophys Acta; 1993 Nov; 1179(3):271-6. PubMed ID: 8218371 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of protein phosphatases (okadaic acid and tautomycin) block sea urchin development. Troll W; Sueoka N; Sueoka E; Laskin JD; Heck DE Biol Bull; 1995; 189(2):201. PubMed ID: 8541399 [No Abstract] [Full Text] [Related]
13. Specific mechanistic aspects of animal tumor promoters: the okadaic acid pathway. Fujiki H; Suganuma M; Nishiwaki S; Yoshizawa S; Yatsunami J; Matsushima R; Furuya H; Okabe S; Matsunaga S; Sugimura T Prog Clin Biol Res; 1992; 374():337-50. PubMed ID: 1620710 [No Abstract] [Full Text] [Related]
14. Oral administration of epidermal growth factor in suckling rats stimulates cell DNA synthesis in fundic and antral gastric mucosae as well as in intestinal mucosa and pancreas. Puccio F; Lehy T Regul Pept; 1988 Jan; 20(1):53-64. PubMed ID: 3258430 [TBL] [Abstract][Full Text] [Related]
15. Neuronal differentiation of Neuro 2a cells by lactacystin and its partial inhibition by the protein phosphatase inhibitors calyculin A and okadaic acid. Tanaka H; Katagiri M; Arima S; Matsuzaki K; Inokoshi J; Omura S Biochem Biophys Res Commun; 1995 Nov; 216(1):291-7. PubMed ID: 7488103 [TBL] [Abstract][Full Text] [Related]
16. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A. Weller M; Malipiero U; Groscurth P; Fontana A Exp Cell Res; 1995 Dec; 221(2):395-403. PubMed ID: 7493639 [TBL] [Abstract][Full Text] [Related]
17. Regulation of the L-type Ca2+ channel current in rat pinealocytes: role of basal phosphorylation. Chik CL; Li B; Karpinski E; Ho AK J Neurochem; 1999 Jan; 72(1):73-80. PubMed ID: 9886056 [TBL] [Abstract][Full Text] [Related]
18. Nonphorbol tumor promoters okadaic acid and calyculin-A induce membrane translocation of protein kinase C. Gopalakrishna R; Chen ZH; Gundimeda U Biochem Biophys Res Commun; 1992 Dec; 189(2):950-7. PubMed ID: 1472068 [TBL] [Abstract][Full Text] [Related]
19. Effects of calyculin A on amylase release in streptolysin-O permeabilized acinar cells. Wagner AC; Schäfer C; Williams JA Biochem Biophys Res Commun; 1992 Dec; 189(3):1606-12. PubMed ID: 1282808 [TBL] [Abstract][Full Text] [Related]
20. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on insulin release from rat pancreatic islets. Tamagawa T; Iguchi A; Uemura K; Miura H; Nonogaki K; Ishiguro T; Sakamoto N Endocrinol Jpn; 1992 Jun; 39(3):325-9. PubMed ID: 1330503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]